Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRevention of Atherosclerosis In High-Risk Patients: Aggressive Risk Modification including Niaspan
2005-005563-28Phase 4Completed
- Sponsor
- Universitätsmedizin Essen
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of niacin in atherosclerosis and cardiac morbidity, sponsored by Universitätsmedizin Essen. Primary endpoint: Change in coronary artery calcium score. Started Aug 2006; status: completed.
02
Drugs
niacin
03
Conditions
atherosclerosiscardiac morbidity
Beyond the preview
Go deeper on 2005-005563-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005563-28.